Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort | Zendy

David L. Sparks | Zendy; Richard J. Kryscio | Zendy; Donald J. Connor | Zendy; Marwan N. Sabbagh | Zendy; Lisa Sparks | Zendy; Yushun Lin | Zendy; Carolyn Liebsack | Zendy

Open Access

Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort

Author(s) -

David L. Sparks,

Richard J. Kryscio,

Donald J. Connor,

Marwan N. Sabbagh,

Lisa Sparks,

Yushun Lin,

Carolyn Liebsack

Publication year - 2010

Publication title -

neurodegenerative diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.98

H-Index - 57

eISSN - 1660-2862

pISSN - 1660-2854

DOI - 10.1159/000295660

Subject(s) - statin , medicine , hazard ratio , cognition , rivermead post concussion symptoms questionnaire , cholesterol , effects of sleep deprivation on cognitive performance , recall , psychology , physical therapy , psychiatry , confidence interval , cognitive psychology

We reported a significant 67% reduction in the hazard risk of incident Alzheimer's disease (AD) with elective statin use in the AD Anti-inflammatory Prevention Trial (ADAPT), without a reduction in risk of incident mild cognitive impairment (MCI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research